1. Daly K, Richardson PJ, Olsen EG, Morgan-Capner P, McSorley C, Jackson G, Jewitt DE. Acute myocarditis. Role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment. Br Heart J 1984;51:30-35.

2. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ.

Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14. Fenoglio JJ Jr, Ursell PC, Kellogg CF, Drusin RE, Weiss MB. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 1983;308:12-18.

Kawai S, Okada R. A histopathological study of dilated cardiomyopathy—with special reference to clinical and pathological comparisons of the degeneration-predominant type and fibrosis-predominant type. Jpn Circ J 1987;51:654-660.

Maisch B, Portig I, Ristic' A, Hufnagel G, Pankuweit S. Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report. Herz 2000;25:200-209. Maisch B, Bültman B, Factor S, Gröne H-J, Hufnagel G, Kawamura K, Kühl U, Olsen EJ, Pankuweit S, Virmani R, McKenna W, Richardson PJ, Thiene G, Schultheiss H-P, Sekiguchi M, Aepinus C, Aitken K, Arbustini E, Archard L, Baboonian C, Bowles N, Broor S, Kandolf R, Liu P, Matsumori A, Pauschinger M, Slenczka W, Sole M, Talwar KK, Towbin J, Tracy S, Bayes de Luna A, Goodwin JF. World Heart Federation consensus conferences' definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat 1999;4:3-4. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987;18:619-624. Doerr W. Morphology of myocarditis. [German.] Verh Dtsch Ges Inn Med 1971;77:301-335. Maisch B. Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury. Springer Semin Immunopathol 1989;11:369-395. Fowles RE, Bieber CP, Stinson EB. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation 1979;59:483-491.

Pankuweit S, Portig I, Eckhardt H, Crombach M, Hufnagel G, Maisch B. Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz 2000;25:221-226.

Maisch B. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy. Basic Res Cardiol 1986;81 Suppl 1:217-241. Maisch B. Immunological mechanisms in human cardiac injury. In: Spry CJF, ed. Immunology and molecular biology of cardiovascular diseases. Lancaster, England: MTP Press, 1987:225-252. Maisch B. The sarcolemma as antigen in the secondary immunopathogenesis of myopericarditis.

Eur Heart J (Suppl J) 1987;8:155-165.

Woodruff JF. Viral myocarditis. A review. Am J Pathol 1980;101:425-484.

Smith WG. Coxsackie B myopericarditis in adults. Am Heart J 1970;80:34-46.

Rose NR, Hill SL. The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol


Caforio AL, Goldman JH, Haven AJ, Baig KM, McKenna WJ. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol 1996;54:157-163.

Lauer B, Schannwell M, Kuhl U, Strauer BE, Schultheiss HP. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000;35:11-18.

Maisch B. The heart in rheumatic disease. Rheumatology 1992;16:81-117.

Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, Crawley R. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol


McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, Klingel KE, Beisel KW, Kandolf R. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 1993;68:159-169.

Paque RE. Role of anti-idiotypic antibodies in induction, regulation, and expression of coxsackie-virus-induced myocarditis. Prog Med Virol 1992;39:204-227.

24. Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N. Pancreatic expression of inter-feron-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 2000;6:693-697.

25. Hill SL, Rose NR. Molecular pathology of autoimmune myocarditis. In: Theofilopoulos AN, Bona CA, eds. The molecular pathology of autoimmune diseases. 2nd ed. Amsterdam: Harwood Academic Publishers (in press).

26. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997;3:1133-1136.

27. Neu N, Craig SW, Rose NR, Alvarez F, Beisel KW. Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. Clin Exp Immunol 1987;69:566-574.

28. Matsumori A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol 1996;11:302-309.

29. Matsumori A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy—role of viruses, cytokines, and nitric oxide. Jpn Circ J 1997;61:275-291.

30. Goin JC, Borda ES, Auger S, Storino R, Sterin-Borda L. Cardiac m2 muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia. Heart 1999;82:273-278.

31. Maisch B, Bauer E, Cirsi M, Kochsiek K. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. Circulation 1993;87 Suppl 4:IV49-IV65.

32. Pankuweit S, Portig I, Lottspeich F, Maisch B. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 1997;29:77-84.

33. Schulze K, Schultheiss HP. The role of the ADP/ATP carrier in the pathogenesis of viral heart disease. Eur Heart J 1995;16 Suppl O:64-67.

34. Wallukat G, Wollenberger A, Morwinski R, Pitschner HF. Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 1995;27:397-406.

35. Limas CJ, Limas C, Kubo SH, Olivari MT. Anti-beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am J Cardiol 1990;65:483-487.

36. Schulze K, Heineman FW, Schultheiss HP, Balaban RS. Impairment of myocardial calcium homeo-stasis by antibodies against the adenine nucleotide translocator. Cell Calcium 1999;25:361-370.

37. Otto LR, Boriack RL, Marsh DJ, Kum JB, Eng C, Burlina AB, Bennett MJ. Long-chain L 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency does not appear to be the primary cause of lipid myopathy in patients with Bannayan-Riley-Ruvalcaba syndrome (BRRS). Am J Med Genet 1999;83:3-5.

38. Maisch B, Lotze U, Schneider J, Kochsiek K. Antibodies to human sinus node in sick sinus syndrome. Pacing Clin Electrophysiol 1986;9:1101-1109.

39. Maisch B, Wedeking U, Kochsiek K. Quantitative assessment of antilaminin antibodies in myocarditis and perimyocarditis. Eur Heart J (Suppl J) 1987;8:233-235.

40. Obermayer U, Scheidler J, Maisch B. Antibodies against micro- and intermediate filaments in carditis and dilated cardiomyopathy—are they a diagnostic marker? Eur Heart J (Suppl J) 1987;8:181-186.

41. Portig I, Pankuweit S, Maisch B. Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. J Mol Cell Cardiol 1997;29:2245-2251.

42. Maisch B, Drude L, Hengstenberg C, Herzum M, Hufnagel G, Kochsiek K, Schmaltz A, Schonian U, Schwab MD. Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies? Basic Res Cardiol 1991;86 Suppl 3:101-114.

43. Klein R, Maisch B, Kochsiek K, Berg PA. Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 1984;58:283-292.

Pohlner K, Portig I, Pankuweit S, Lottspeich F, Maisch B. Identification of mitochondrial antigens recognized by antibodies in sera of patients with idiopathic dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol 1997;80:1040-1045. Naparstek Y, Plotz PH. The role of autoantibodies in autoimmune disease. Annu Rev Immunol 1993;11:79-104.

Khaw BA, Narula J, Sharaf AR, Nicol PD, Southern JF, Carles M. SR-Ca2+ ATPase as an autoimmunogen in experimental myocarditis. Eur Heart J 1995;16 Suppl O:92-96. De Scheerder I, De Buyzere M, Algoed L, De Lange M, Delanghe J, Bogaert AM, Clement DL. Characteristic anti-heart antibody patterns in post-cardiac injury syndrome, endocarditis and acute myocarditis. Eur Heart J (Suppl J) 1987;8:237-238.

Klein R, Seipel L, Kleemann U, Hassenstein P, Berg PA. Relevance of antimitochondrial antibodies (anti-M7) in cardiac diseases. Eur Heart J (Suppl J) 1987;8:223-226.

Maisch B, Trostel-Soeder R, Stechemesser E, Berg PA, Kochsiek K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp

Immunol 1982;48:533-545.

Maisch B, Bauer E, Hufnagel G, Pfeifer U, Rohkamm R. The use of endomyocardial biopsy in heart failure. Eur Heart J (Suppl H) 1988;9:59-71.

Maisch B, Schwab D, Bauer E, Sandhage K, Schmaltz AA, Wimmer M. Antimyolemmal antibodies in myocarditis in children. Eur Heart J (Suppl J) 1987;8:167-173.

Schultheiss H-P. The mitochondrium as antigen in inflammatory heart disease. Eur Heart J (Suppl J) 1987;8:203-210.

Schultheiss H-P, Kühl U. Charakterisierung verschiedener Autoantikörper gegen myokardiale Matrixproteine bei Myokarditis und Dilativer Kardiomyopathie (abstract). Klin Wochenschr (Suppl IX) 1987;65:263-264.

Maisch B, Maisch S, Kochsiek K. Immune reactions in tuberculous and chronic constrictive pericarditis. Clinical data and diagnostic significance of antimyocardial antibodies. Am J Cardiol 1982;50:1007-1013.

Maisch B, Kochsiek K. Humoral immune reactions in uremic pericarditis. Am J Nephrol 1983;3:264-271.

Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983;52:1072-1078. Maisch B, Buschel G, Izumi T, Eigel P, Regitz V, Deeg P, Pfeifer U, Schmaltz A, Herzum M, Liebau G, Kochsiek K. Four years of experience in endomyocardial biopsy—an immunohistologic approach. Heart Vessels Suppl 1985;1:59-67.

Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985;17:603-617. Maisch B. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute myocarditis and congestive cardiomyopathy. In: Chazov EI, Smirnov VN, Organov RG, eds. Cardiology: an international perspective. New York: Plenum Press, 1984:1327-1338. Maisch B. Surface antigens of adult heart cells and their use in diagnosis. Basic Res Cardiol 1985;80 Suppl 1:47-51.

Maisch B, Trostel-Soeder R, Berg PA, Kochsiek K. Assessment of antibody mediated cytolysis of adult cardiocytes isolated by centrifugation in a continuous gradient of Percoll in patients with acute myocarditis. J Immunol Methods 1981;44:159-169.

Maisch B. Immunologic regulator and effector mechanisms in myocarditis and perimyocarditis.

Heart Vessels Suppl 1985;1:209-217.

63. Caforio AL, Bauce B, Boffa GM, De Cian F, Angelini A, Melacini P, Razzolini R, Fasoli G, Chioin R, Schiaffino S, Thiene G, Dalla Volta S. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy. G Ital Cardiol


64. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989;64:97-103.

65. Schultheiss HP. The significance of autoantibodies against the ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy—clinical and experimental data. Springer Semin Immunopathol 1989;11:15-30.

66. Müller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation


67. Kirsner AB, Hess EV, Fowler NO. Immunologic findings in idiopathic cardiomyopathy: a prospective serial study. Am Heart J 1973;86:625-630.

68. Limas CJ, Goldenberg IF. Autoantibodies against cardiac ß-adrenoceptors in human dilated cardiomyopathy (abstract). Circulation 1987;76 Suppl 4:262.

69. Wallukat G, Boewer V. Stimulation of chronotropic beta-adrenoceptors of cultures neonatal rat heart myocytes by the serum of gammaglobulin fraction of patients with dilated cardiomyopathy and myocarditis. In: International Symposium: heart failure, pathogenesis and therapy, Berlin 28.2.-2.3, 1988. [Book of abstracts.] Berlin: Universitätsverlag, 1988:A24.

70. Magnusson Y, Wallukat G, Guillet JG, Hjalmarson A, Hoebeke J. Functional analysis of rabbit anti-peptide antibodies which mimic autoantibodies against the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Autoimmunol 1991;4:893-905.

71. Inomata T, Watanabe T, Haga M, Hirahara H, Abo T, Okura Y, Hanawa H, Kodama M, Izumi T. Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis. Jpn Heart J 2000;41:507-517.

72. Hammond EH, Menlove RL, Anderson JL. Immunofluorescence microscopy in the diagnosis and follow-up of patients suspected of having inflammatory heart disease. In: Schultheiss H-P, ed. New concepts in viral heart disease: virology, immunology and clinical management. Berlin:

Springer-Verlag, 1988:303-311.

73. Schulze K, Becker BF, Schauer R, Schultheiss HP. Antibodies to ADP-ATP carrier—an autoantigen in myocarditis and dilated cardiomyopathy—impair cardiac function. Circulation 1990;81:959-969.

74. Schwimmbeck PL, Schultheiss H-P, Strauer BE. Identification of a main autoimmunogenic epitope of the adenine nucleotide translocator which cross-reacts with coxsackie B3 virus: use in the diagnosis of myocarditis and dilative cardiomyopathy (abstract). Circulation 1989;80 Suppl 2:II-665.

75. Takemoto M, Kusachi S, Urabe N, Inoue K, Tsuji T. Auto-antibody against adenine nucleotide translocator in dilated cardiomyopathy and myocarditis—incidence and relation to cardiac function and morphology. Jpn Circ J 1993;57:1150-1158.

76. Liao YH. Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardio-myopathy. Int J Cardiol 1996;54:165-169.

77. Schulze K, Becker BF, Schultheiss HP. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 1989;64:179-192.

78. Morad M, Nabauer M, Schultheiss H-P. Antibodies and autoantibodies against ADP/ATP carrier enhance calcium current in isolated ventricular myocytes. In: Schultheiss H-P, ed. New concepts in viral heart disease: virology, immunology and clinical management. Berlin: Springer-Verlag,


79. Schultheiss HP, Schulze K, Schauer R, Witzenbichler B, Strauer BE. Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure? Circ Res 1995;76:64-72. Kühl U, Ulrich G, Melzner B, Schoeber B, Morad M, Schultheiss HP. Characterization of autoantibodies against the Ca2+-channel inducing cytotoxicity by enhancement of calcium permeability. In: Seventh International Congress of Immunology, July 30-August 5, 1989: Abstracts. Stuttgart: Gustav Fischer, 1989:116-117.

Kühl U, Ulrich G, Schultheiss H-P. Cross-reactivity of antibodies to the ADP/ATP translocator of the inner mitochondrial membrane with the cell surface of cardiac myocytes. Eur Heart J (Suppl J) 1987;8:219-222.

Wittner B, Maisch B, Kochsiek K. Quantification of antimyosin antibodies in experimental myocarditis by a new solid phase fluorometric assay. J Immunol Methods 1983;64:239-247. Beisel KW. Immunogenetic basis of myocarditis: role of fibrillary antigens. Springer Semin Immunopathol 1989;11:31-42.

Fairweather D, Lawson CM, Chapman AJ, Brown CM, Booth TW, Papadimitriou JM, Shellam GR. Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin. Immunology 1998;94:263-270.

Schwimmbeck PL, Bland NK, Schultheiss HP, Strauer BE. The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy. Eur Heart J 1991;12 Suppl D:76-80.

Matsumori A, Yamada T, Sasayama S. Antimyosin antibody imaging in clinical myocarditis and cardiomyopathy: principle and application. Int J Cardiol 1996;54:183-190.

Ansari AA, Wang YC, Danner DJ, Gravanis MB, Mayne A, Neckelmann N, Sell KW, Herskowitz A.

Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol 1991;139:337-354.

Wolff PG, Kuhl U, Schultheiss HP. Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J 1989;117:1303-1309.

Sato Y, Matsumori A, Sasayama S. Autoantibodies against vimentin in a murine model of myocarditis. Autoimmunity 1994;18:145-148.

Kasahara H, Itoh M, Sugiyama T, Kido N, Hayashi H, Saito H, Tsukita S, Kato N. Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides. J Clin Invest 1994;94:1026-1036.

Hufnagel G, Maisch B. Expression of MHC class I and II antigens and the Il-2 receptor in rejection, myocarditis and dilated cardiomyopathy. Eur Heart J 1991;12 Suppl D:137-140. Herskowitz A, Neumann DA, Rose NR, Beschorner WE, Sell KL, Ansari AA, Baughman KL. Histocompatibility (MHC) antigens in human myocarditis: new markers of immune-mediated disease (abstract). Circulation 1989;80 Suppl 2:II-676.

Herzum M, Maisch B, Kochsiek K. Circulating immune complexes in perimyocarditis and infective endocarditis. Eur Heart J (Suppl J) 1987;8:323-325.

Cristea A, Rus H, Niculescu F, Bedeleanu D, Vlaicu R. Characterization of circulating immune complexes in heart disease. Immunol Lett 1986;13:45-49.

Zinkernagel RM. Immunology taught by viruses. Science 1996;271:173-178.

Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72:561-566.

Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-241.

Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM. Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. J Card Fail 1997;3:117-124.

99. Satoh M, Tamura G, Segawa I, Tashiro A, Hiramori K, Satodate R. Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Arch 1996;427:503-509.

100. Shioi T, Matsumori A, Nishio R, Ono K, Kakio T, Sasayama S. Protective role of interleukin-12 in viral myocarditis. J Mol Cell Cardiol 1997;29:2327-2334.

101. Shioi T, Matsumori A, Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 1996;94:2930-2937.

102. de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvular heart disease. Br Heart J 1995;74:426-430.

103. Mikami S, Kawashima S, Kanazawa K, Hirata K, Katayama Y, Hotta H, Hayashi Y, Ito H, Yokoyama M. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. Biochem Biophys Res Commun 1996;220:983-989.

104. Bachmaier K, Neu N, Pummerer C, Duncan GS, Mak TW, Matsuyama T, Penninger JM. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 1997;96:585-591.

105. Ishiyama S, Hiroe M, Nishikawa T, Abe S, Shimojo T, Ito H, Ozasa S, Yamakawa K, Matsuzaki M, Mohammed MU, Nakazawa H, Kasajima T, Marumo F. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 1997;95:489-496.

106. Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson CB, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol 1997;29:491-502.

107. Noutsias M, Seeberg B, Schultheiss H-P, Kühl U. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation


108. Devaux B, Scholz D, Hirche A, Klovekorn WP, Schaper J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 1997;18:470-479.

109. Pummerer CL, Grassl G, Sailer M, Bachmaier KW, Penninger JM, Neu N. Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells. Lab Invest 1996;74:845-852.

110. Anderson JL, Carlquist JF, Hammond EH. Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet 1982;2:1124-1127.

Was this article helpful?

0 0

Post a comment